Hilltop Holdings’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$225K Hold
3,850
– – 0.02% 618
2026
Q2
$216K Buy
+3,850
New +$200K 0.02% 639
2026
Q1
– Sell
-5,668
Closed -$219K – 863
2025
Q4
$219K Sell
5,668
-145
-2% -$5.53K 0.01% 821
2025
Q3
$205K Buy
+5,813
New +$210K 0.01% 870

Other funds holding RPRX

Hilltop Holdings's RPRX Position: Q3 2026 in Review

Hilltop Holdings held its Royalty Pharma (RPRX) position steady in Q3 2026 at 3,850 shares worth $225K. The position accounts for 0.02% of the portfolio, ranked #618.

Hilltop Holdings first reported a position in RPRX in Q3 2025 and has held it in 4 quarters since. 707 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

  • Hilltop Holdings held 3,850 shares of Royalty Pharma worth $225K as of Q3 2026.
  • Hilltop Holdings left its Royalty Pharma share count unchanged in Q3 2026.
  • Royalty Pharma made up 0.02% of Hilltop Holdings's portfolio in Q3 2026, its #618 holding.
  • Hilltop Holdings first reported a position in Royalty Pharma in Q3 2025 and has held it in 4 quarters since.
  • 707 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on Hilltop Holdings's 13F filing for Q3 2026, filed 16 Nov 2026.